Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity - Narrative (Details)

v3.23.1
Stockholders' Equity - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 3 Months Ended
Feb. 01, 2022
Jan. 31, 2022
Mar. 31, 2023
Jan. 05, 2023
Dec. 31, 2022
Apr. 30, 2022
Oct. 31, 2021
Feb. 28, 2021
Dec. 31, 2020
Oct. 27, 2020
Class of Stock [Line Items]                    
Common stock, shares authorized (in shares)     1,000,000,000   1,000,000,000          
Common stock, par value (in dollars per share)     $ 0.0001   $ 0.0001          
Common stock, shares outstanding (in shares)     104,007,810   103,153,337          
Common stock, shares issued (in shares)     104,469,310   103,153,337          
Stock repurchase program authorized shares       5,000,000            
Stock repurchased (in shares)     461,500   0          
Aggregate repurchase price     $ 475   $ 0          
Number of warrants (in shares)     6,632,561   6,632,561          
Warrants                    
Class of Stock [Line Items]                    
Warrant, term                 3 years  
Number of warrants (in shares)             2,811,315 3,840,000 2,160,000 2,160,000
Exercise price per share (in dollars per share)             $ 1.4246      
Additional warrant shares registered (as a percent)           250.00%        
Common Stock | Warrants                    
Class of Stock [Line Items]                    
Exercise price per share (in dollars per share)               $ 2.25 $ 4.00  
At Market Issuance Sales Agreement                    
Class of Stock [Line Items]                    
Common stock, par value (in dollars per share)   $ 0.0001                
Aggregate offering price   $ 100,000                
Aggregate net proceeds received $ 200                  
Wainwright Sales Agreement                    
Class of Stock [Line Items]                    
Aggregate offering price     $ 95,400